TY - JOUR
T1 - Alternative approaches for identifying acute systemic toxicity
T2 - Moving from research to regulatory testing
AU - Hamm, Jon
AU - Sullivan, Kristie
AU - Clippinger, Amy J.
AU - Strickland, Judy
AU - Bell, Shannon
AU - Bhhatarai, Barun
AU - Blaauboer, Bas
AU - Casey, Warren
AU - Dorman, David
AU - Forsby, Anna
AU - Garcia-Reyero, Natàlia
AU - Gehen, Sean
AU - Graepel, Rabea
AU - Hotchkiss, Jon
AU - Lowit, Anna
AU - Matheson, Joanna
AU - Reaves, Elissa
AU - Scarano, Louis
AU - Sprankle, Catherine
AU - Tunkel, Jay
AU - Wilson, Dan
AU - Xia, Menghang
AU - Zhu, Hao
AU - Allen, David
N1 - Funding Information:
This workshop was cosponsored by NICEATM, the PETA International Science Consortium Ltd., and the Physicians Committee for Responsible Medicine. Special thanks to the workshop organizing committee: David Allen, Warren Casey, Amy Clippinger, Evisabel Craig, Kelly Coleman, Jose Gayoso, Rabea Graepel, Jon Hamm, Anna Lowit, Julia Melia, Larry Milchak, William Polk, Pilar Prieto, Elissa Reaves, John Redden, Louis (“Gino”) Scarano, PV Shah, Judy Strickland, Kristie Sullivan, Jay Tunkel, Garland Waleko, Dan Wilson, and Hao Zhu. With thanks to the webinar and workshop presenters, and those who assisted during the planning and hosting of the workshop, Aryenish Birdie, Hayley Haynes, Catherine Sprankle, Sharon Barbour, and Shannon Bell. Thanks also to Pilar Prieto (EURL-ECVAM) for her careful technical review and editing of this report. This project was funded in part with federal funds from the NIEHS, NIH under Contract No. HHSN273201500010C to ILS in support of NICEATM.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/6
Y1 - 2017/6
N2 - Acute systemic toxicity testing provides the basis for hazard labeling and risk management of chemicals. A number of international efforts have been directed at identifying non-animal alternatives for in vivo acute systemic toxicity tests. A September 2015 workshop, Alternative Approaches for Identifying Acute Systemic Toxicity: Moving from Research to Regulatory Testing, reviewed the state-of-the-science of non-animal alternatives for this testing and explored ways to facilitate implementation of alternatives. Workshop attendees included representatives from international regulatory agencies, academia, nongovernmental organizations, and industry. Resources identified as necessary for meaningful progress in implementing alternatives included compiling and making available high-quality reference data, training on use and interpretation of in vitro and in silico approaches, and global harmonization of testing requirements. Attendees particularly noted the need to characterize variability in reference data to evaluate new approaches. They also noted the importance of understanding the mechanisms of acute toxicity, which could be facilitated by the development of adverse outcome pathways. Workshop breakout groups explored different approaches to reducing or replacing animal use for acute toxicity testing, with each group crafting a roadmap and strategy to accomplish near-term progress. The workshop steering committee has organized efforts to implement the recommendations of the workshop participants.
AB - Acute systemic toxicity testing provides the basis for hazard labeling and risk management of chemicals. A number of international efforts have been directed at identifying non-animal alternatives for in vivo acute systemic toxicity tests. A September 2015 workshop, Alternative Approaches for Identifying Acute Systemic Toxicity: Moving from Research to Regulatory Testing, reviewed the state-of-the-science of non-animal alternatives for this testing and explored ways to facilitate implementation of alternatives. Workshop attendees included representatives from international regulatory agencies, academia, nongovernmental organizations, and industry. Resources identified as necessary for meaningful progress in implementing alternatives included compiling and making available high-quality reference data, training on use and interpretation of in vitro and in silico approaches, and global harmonization of testing requirements. Attendees particularly noted the need to characterize variability in reference data to evaluate new approaches. They also noted the importance of understanding the mechanisms of acute toxicity, which could be facilitated by the development of adverse outcome pathways. Workshop breakout groups explored different approaches to reducing or replacing animal use for acute toxicity testing, with each group crafting a roadmap and strategy to accomplish near-term progress. The workshop steering committee has organized efforts to implement the recommendations of the workshop participants.
UR - http://www.scopus.com/inward/record.url?scp=85009932470&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009932470&partnerID=8YFLogxK
U2 - 10.1016/j.tiv.2017.01.004
DO - 10.1016/j.tiv.2017.01.004
M3 - Review article
C2 - 28069485
AN - SCOPUS:85009932470
SN - 0887-2333
VL - 41
SP - 245
EP - 259
JO - Toxicology in Vitro
JF - Toxicology in Vitro
ER -